data

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a…

1 week ago

Artmarket.com: Double-digit growth in Q2 2025, Revolutionary Artprice-Perplexity AI rapprochement: The Mixed Subscription for the Second Half of 2025/2026 Will Redefine the Intelligence of the Art Market

PARIS, Aug. 7, 2025 /PRNewswire/ -- The Board of Directors, its founding President, and the employees of Artprice are mobilizing…

1 week ago

Dun & Bradstreet India Celebrates 30 Years of Empowering Business Growth

MUMBAI, India, Aug. 6, 2025 /PRNewswire/ -- Dun & Bradstreet India, a leading provider of business decisioning data and analytics, proudly celebrates…

1 week ago

Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Mechelen, Belgium; August 6, 2025, 7:30 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG) today…

1 week ago

Brandwatch and Trajaan Partner to Bring World-Class Search Intelligence to Consumer Insights

CHICAGO, Aug. 5, 2025 /PRNewswire/ -- Brandwatch, the leading digital consumer intelligence platform, today announced a strategic partnership with Trajaan,…

1 week ago

Seegene Unveils CURECA and STAgora at ADLM 2025, Advancing the Next Stage of Diagnostics

Dr. Jong-Yoon Chun, Chairman and CEO of Seegene, highlights progress toward fully automated and data-driven molecular testingIntroduction of CURECA™, the…

2 weeks ago

Inveniam and MANTRA Announce Strategic Partnership to Build a Global Institutional Real-World Asset Ecosystem Anchored in the UAE and United States

Inveniam invests $20 million in MANTRA to advance institutional infrastructure for tokenized private real-world assets from the UAE to global…

2 weeks ago

Aicuris Presents Pharmacokinetic Data from the First-in-Human Clinical Trial of AIC468, a Novel Antisense Oligonucleotide Targeting BK Virus, at World Transplant Congress

Initial results from the First in Human (FIH) Phase 1 trial evaluating AIC468, a 2nd generation antisense oligonucleotide (ASO), in…

2 weeks ago

IBM Report: 13% Of Organizations Reported Breaches Of AI Models Or Applications, 97% Of Which Reported Lacking Proper AI Access Controls

U.S. breach costs rise to $10.22 million, despite the global average cost of a breach decreasing to $4.44 million; Only…

2 weeks ago

ELLKAY President & CEO Joins White House Health IT Summit to Help Push Interoperability Forward

ELMWOOD PARK, N.J., August 1, 2025 /PRNewswire/ -- ELLKAY, a leading strategic data management partner in healthcare, is proud to announce…

2 weeks ago